134 related articles for article (PubMed ID: 35368958)
1. SPINK5 is a Tumor-Suppressor Gene Involved in the Progression of Nonsmall Cell Lung Carcinoma through Negatively Regulating PSIP1.
Zhang J; Rong J; Ge W; Wang J; Wang W; Chi H
J Healthc Eng; 2022; 2022():2209979. PubMed ID: 35368958
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
[TBL] [Abstract][Full Text] [Related]
3. SPINK5 inhibits esophageal squamous cell carcinoma metastasis via immune activity.
Chen J; Lu J; Chen Z; Liu Z; Sun Y; He S; Mi Y; Gao Y; Shen D; Lin Q
J Gene Med; 2024 Mar; 26(3):e3667. PubMed ID: 38442944
[TBL] [Abstract][Full Text] [Related]
4. A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer.
Wang Q; Lv Q; Bian H; Yang L; Guo KL; Ye SS; Dong XF; Tao LL
Cancer Med; 2019 May; 8(5):2360-2371. PubMed ID: 30868765
[TBL] [Abstract][Full Text] [Related]
5. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
Luo T; Yan L; Liu H
J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the Tumor Suppressor Gene SPINK5 via EHMT2 Induces the Oral Squamous Cell Carcinoma Development.
Sun S; Su G; Zheng X
Mol Biotechnol; 2024 Feb; 66(2):208-221. PubMed ID: 37071303
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
8. CEBPB knockdown sensitizes nasopharyngeal carcinoma cells to cisplatin by promoting the expression of serine protease inhibitor Kazal-type 5.
Liu H; Huang Q; Lv Y; Dong Y; Song D
Anticancer Drugs; 2022 Jan; 33(1):e327-e335. PubMed ID: 34387602
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
[TBL] [Abstract][Full Text] [Related]
13. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
15. miR‑491‑3p functions as a tumor suppressor in non‑small cell lung cancer by targeting fibroblast growth factor 5.
Zhang G; Zheng H; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866594
[TBL] [Abstract][Full Text] [Related]
16. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
Sun B; Zhao J; Shao ZY
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3083-3090. PubMed ID: 35587058
[TBL] [Abstract][Full Text] [Related]
17. m
Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1.
Wang S; Sun H; Zhan X; Wang Q
Int J Mol Med; 2020 Jan; 45(1):33-44. PubMed ID: 31746372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
